Corporate profile
Bayer Schering Pharma is one of the ten largest specialty pharmaceutical companies in the world. We market our products in more than 100 countries, and in 2008 generated sales of over €10.7 billion.
Approx. 38,000 members of staff currently work for Bayer Schering Pharma worldwide – more than 5,600 in research and development alone. We aim to improve people’s quality of life with our products. To achieve this, we concentrate on the research and development of innovative drugs and novel therapeutic approaches. At the same time, we are constantly improving established products. In this context, Bayer Schering Pharma uses experience it has gained from over a century in the business. We concentrate on four business units in which we make essential contributions to medical progress:
Facts and Figures
| Established: | In 2006 Bayer AG acquired Schering AG, Germany, to combine its pharmaceutical business with Schering AG's business. |
| Headquarter: | Berlin |
| Headcount: | Approx. 38,000 members of staff worldwide (Full time equivalents as of December 31, 2008.) |
| Sales in 2008: | EUR 10,704 million |
| Main research locations: | Berlin and Wuppertal in Germany; Berkeley, USA. |
| Production locations: | Europe, United States, Latin America and Asia. |
| Subsidiaries: | The company has subsidiaries in over 100 countries worldwide. |
Main R&D fields
| Location | Main field |
|---|---|
| Berlin: | Diagnostic Imaging, Oncology and Women's Healthcare |
| Wuppertal: | Cardiology and Oncology |
| Berkeley: | Applied research and life cycle management in hemophilia and Multiple Sclerosis |
Information for Download
